Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18199798 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)
Conditions: Type 2 Diabetes;   Nephropathy
Interventions: Drug: MK0954, losartan / Duration of Treatment: mean 3.4 years;   Drug: Placebo / Duration of Treatment: mean 3.4 years

Indicates status has not been verified in more than two years